AGIOS PHARMACEUTICALS, INC.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | 124.2% | 124.2% | 111.6% |
| FY2022 | -21.1% | -21.1% | -18.7% |
| FY2023 | -43.4% | -43.4% | -37.6% |
| FY2024 | 43.7% | 43.7% | 40.5% |
| FY2025 | -34.6% | -34.6% | -31.8% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | 124.2% | 124.2% | 111.6% |
| FY2022 | -21.1% | -21.1% | -18.7% |
| FY2023 | -43.4% | -43.4% | -37.6% |
| FY2024 | 43.7% | 43.7% | 40.5% |
| FY2025 | -34.6% | -34.6% | -31.8% |